| 000 | 01673 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517153045.0 | ||
| 264 | 0 | _c20180419 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1522-9629 | ||
| 024 | 7 |
_a10.1016/j.pupt.2017.05.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAmison, R T | |
| 245 | 0 | 0 |
_aLipopolysaccharide (LPS) induced pulmonary neutrophil recruitment and platelet activation is mediated via the P2Y _h[electronic resource] |
| 260 |
_bPulmonary pharmacology & therapeutics _c08 2017 |
||
| 300 |
_a62-68 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 |
_aLipopolysaccharides _xadministration & dosage |
| 650 | 0 | 4 |
_aLung _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeutrophil Infiltration _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPurinergic P2X Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2Y _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2Y1 _xmetabolism |
| 700 | 1 | _aArnold, S | |
| 700 | 1 | _aO'Shaughnessy, B G | |
| 700 | 1 | _aCleary, S J | |
| 700 | 1 | _aOfoedu, J | |
| 700 | 1 | _aIdzko, M | |
| 700 | 1 | _aPage, C P | |
| 700 | 1 | _aPitchford, S C | |
| 773 | 0 |
_tPulmonary pharmacology & therapeutics _gvol. 45 _gp. 62-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pupt.2017.05.005 _zAvailable from publisher's website |
| 999 |
_c27156759 _d27156759 |
||